Literature DB >> 20023637

Salt-sensitive hypertension in circadian clock-deficient Cry-null mice involves dysregulated adrenal Hsd3b6.

Masao Doi1, Yukari Takahashi, Rie Komatsu, Fumiyoshi Yamazaki, Hiroyuki Yamada, Shogo Haraguchi, Noriaki Emoto, Yasushi Okuno, Gozoh Tsujimoto, Akihiro Kanematsu, Osamu Ogawa, Takeshi Todo, Kazuyoshi Tsutsui, Gijsbertus T J van der Horst, Hitoshi Okamura.   

Abstract

Malfunction of the circadian clock has been linked to the pathogenesis of a variety of diseases. We show that mice lacking the core clock components Cryptochrome-1 (Cry1) and Cryptochrome-2 (Cry2) (Cry-null mice) show salt-sensitive hypertension due to abnormally high synthesis of the mineralocorticoid aldosterone by the adrenal gland. An extensive search for the underlying cause led us to identify type VI 3beta-hydroxyl-steroid dehydrogenase (Hsd3b6) as a new hypertension risk factor in mice. Hsd3b6 is expressed exclusively in aldosterone-producing cells and is under transcriptional control of the circadian clock. In Cry-null mice, Hsd3b6 messenger RNA and protein levels are constitutively high, leading to a marked increase in 3beta-hydroxysteroid dehydrogenase-isomerase (3beta-HSD) enzymatic activity and, as a consequence, enhanced aldosterone production. These data place Hsd3b6 in a pivotal position through which circadian clock malfunction is coupled to the development of hypertension. Translation of these findings to humans will require clinical examination of human HSD3B1 gene, which we found to be functionally similar to mouse Hsd3b6.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20023637     DOI: 10.1038/nm.2061

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  46 in total

Review 1.  Molecular mechanisms of human hypertension.

Authors:  R P Lifton; A G Gharavi; D S Geller
Journal:  Cell       Date:  2001-02-23       Impact factor: 41.582

Review 2.  Sleep apnea and heart failure: Part II: central sleep apnea.

Authors:  T Douglas Bradley; John S Floras
Journal:  Circulation       Date:  2003-04-08       Impact factor: 29.690

Review 3.  Coordination of circadian timing in mammals.

Authors:  Steven M Reppert; David R Weaver
Journal:  Nature       Date:  2002-08-29       Impact factor: 49.962

4.  Zone-specific expression of aldosterone synthase cytochrome P-450 and cytochrome P-45011 beta in rat adrenal cortex: histochemical basis for the functional zonation.

Authors:  T Ogishima; H Suzuki; J Hata; F Mitani; Y Ishimura
Journal:  Endocrinology       Date:  1992-05       Impact factor: 4.736

5.  Role of DBP in the circadian oscillatory mechanism.

Authors:  S Yamaguchi; S Mitsui; L Yan; K Yagita; S Miyake; H Okamura
Journal:  Mol Cell Biol       Date:  2000-07       Impact factor: 4.272

6.  Primary aldosteronism: treatment with trilostane.

Authors:  B Winterberg; W Vetter; H Groth; P Greminger; H Vetter
Journal:  Cardiology       Date:  1985       Impact factor: 1.869

Review 7.  Eplerenone: cardiovascular protection.

Authors:  Nancy J Brown
Journal:  Circulation       Date:  2003-05-20       Impact factor: 29.690

8.  Structure and expression of a new complementary DNA encoding the almost exclusive 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4-isomerase in human adrenals and gonads.

Authors:  E Rhéaume; Y Lachance; H F Zhao; N Breton; M Dumont; Y de Launoit; C Trudel; V Luu-The; J Simard; F Labrie
Journal:  Mol Endocrinol       Date:  1991-08

9.  Trilostane, an orally active inhibitor of steroid biosynthesis.

Authors:  G O Potts; J E Creange; H R Hardomg; H P Schane
Journal:  Steroids       Date:  1978-09       Impact factor: 2.668

10.  Congenital adrenal hyperplasia due to point mutations in the type II 3 beta-hydroxysteroid dehydrogenase gene.

Authors:  E Rhéaume; J Simard; Y Morel; F Mebarki; M Zachmann; M G Forest; M I New; F Labrie
Journal:  Nat Genet       Date:  1992-07       Impact factor: 38.330

View more
  152 in total

1.  USP2a protein deubiquitinates and stabilizes the circadian protein CRY1 in response to inflammatory signals.

Authors:  Xin Tong; Katie Buelow; Anirvan Guha; Rebecca Rausch; Lei Yin
Journal:  J Biol Chem       Date:  2012-06-05       Impact factor: 5.157

2.  CRY1, CRY2 and PRKCDBP genetic variants in metabolic syndrome.

Authors:  Leena Kovanen; Kati Donner; Mari Kaunisto; Timo Partonen
Journal:  Hypertens Res       Date:  2014-11-13       Impact factor: 3.872

Review 3.  Regulation of metabolism: the circadian clock dictates the time.

Authors:  Saurabh Sahar; Paolo Sassone-Corsi
Journal:  Trends Endocrinol Metab       Date:  2011-12-12       Impact factor: 12.015

Review 4.  Advances in understanding the peripheral circadian clocks.

Authors:  Jacob Richards; Michelle L Gumz
Journal:  FASEB J       Date:  2012-06-01       Impact factor: 5.191

5.  A wheel of time: the circadian clock, nuclear receptors, and physiology.

Authors:  Xiaoyong Yang
Journal:  Genes Dev       Date:  2010-04-15       Impact factor: 11.361

6.  Mad dogs and Englishmen go out in the midday sun.

Authors:  Michael Bursztyn
Journal:  Sleep       Date:  2010-03       Impact factor: 5.849

Review 7.  Clocks not winding down: unravelling circadian networks.

Authors:  Eric E Zhang; Steve A Kay
Journal:  Nat Rev Mol Cell Biol       Date:  2010-11       Impact factor: 94.444

8.  Lateralization of the central circadian pacemaker output: a test of neural control of peripheral oscillator phase.

Authors:  Carrie E Mahoney; Daniel Brewer; Mary K Costello; Judy McKinley Brewer; Eric L Bittman
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-06-30       Impact factor: 3.619

9.  Development of monoclonal antibodies against human CYP11B1 and CYP11B2.

Authors:  Celso E Gomez-Sanchez; Xin Qi; Carolina Velarde-Miranda; Maria W Plonczynski; C Richard Parker; William Rainey; Fumitoshi Satoh; Takashi Maekawa; Yasuhiro Nakamura; Hironobu Sasano; Elise P Gomez-Sanchez
Journal:  Mol Cell Endocrinol       Date:  2013-12-08       Impact factor: 4.102

10.  Development of monoclonal antibodies against the human 3β-hydroxysteroid dehydrogenase/isomerase isozymes.

Authors:  Celso E Gomez-Sanchez; Mark Lewis; Kazutaka Nanba; William E Rainey; Maniselvan Kuppusamy; Elise P Gomez-Sanchez
Journal:  Steroids       Date:  2017-08-31       Impact factor: 2.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.